HCRT and Alzheimer disease: Future investigations, including repeated MCH/HCRT-1 level measurements in combination with sleep-wake-actigraphy and assessment of sleep by questionnaires, histochemical determinations of MCH in animal and post-mortem tissues are warranted to understand the hypothalamic impact in AD in greater detail.